Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
19,218 Lung Cancer
clinical trials

Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Rancho Cucamonga
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Downtown Commons
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakeland Medical Center Saint Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Smilow Cancer Hospital-Torrington Care Center
mi
from
Torrington, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
ProHealth Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
WellSpan Health-York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
National Jewish Health-Northern Hematology Oncology
mi
from
Thornton, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
William E Kahlert Regional Cancer Center/Sinai Hospital
mi
from
Westminster, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Wellspan Health - York Cancer Center
mi
from
York, PA
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Lycera Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2 Study of Combination Immunotherapy and mRNA Vaccine in Subjects With NSCLC
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Small-Cell Lung Cancer Clinical Trial
Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Texas Oncology-McKinney
mi
from
McKinney, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Local Consolidation Therapy (LCT) After Nivolumab and Ipilimumab (LONESTAR)
Status: Enrolling, Phase III
Updated: 12/31/1969
MD Anderson Cancer Center at Katy
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Local Consolidation Therapy (LCT) After Nivolumab and Ipilimumab (LONESTAR)
Status: Enrolling, Phase III
Updated: 12/31/1969
MD Anderson Cancer Center Bay Area
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
PCR Oncology
mi
from
Arroyo Grande, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
AIS Cancer Center at San Joaquin Community Hospital
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Center of Baton Rouge
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Nebraska Medicine-Bellevue
mi
from
Bellevue, NE
Click here to add this to my saved trials
Nonsmall Cell Lung Cancer Clinical Trial
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
Status: Enrolling, Phase III
Updated: 12/31/1969
UT/Erlanger Oncology & Hematology
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
[Site 12] University of Texas M.D. Anderson Cancer Center - Investigational Cancer Therapeutics
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Study of AM0010 With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Frederick Regional Health System James M Stockman Cancer Institute
mi
from
Frederick, MD
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Study of AM0010 With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Joseph Heritage Hospital
mi
from
Fullerton, CA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Study of AM0010 With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Winthrop University Hospital and Clinics
mi
from
Mineola, NY
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Study of AM0010 With Nivolumab Compared to Nivolumab Alone Second-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hawaii Cancer Care, Inc.
mi
from
Honolulu, HI
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Study of AM0010 With Nivolumab Compared to Nivolumab Alone Second-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Innovative Clinical Research Institute (ICRI)
mi
from
Whittier, CA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
REGN2810 (Anti-PD-1 Antibody), Ipilimumab (Anti-CTLA-4 Antibody), and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Research Site
mi
from
Orange City, FL
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lafayette, IN
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Advanced Non-Small Cell Lung Carcinoma Clinical Trial
A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Research Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
Advanced Non-Small Cell Lung Carcinoma Clinical Trial
A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Research Site
mi
from
Canton, OH
Click here to add this to my saved trials
Non-Small-Cell Lung Clinical Trial
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange
mi
from
Orange, CA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Collection of Sputum and Labeling for Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Radiology Associates of Albuquerque
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Collection of Sputum and Labeling for Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Atlantic Respiratory Institute
mi
from
Summit, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
NEXT Oncology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Middletown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
MGH Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
QUILT-2.023: A Study of ALT-803, a Fusion Protein Activator of Natural Killer and T-Cells, in Combination With Pembrolizumab vs Pembrolizumab Alone as First-Line Treatment for Patients With Metastatic NSCLC.
Status: Enrolling, Phase II
Updated: 12/31/1969
Lehigh Valley
mi
from
Allentown, PA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
QUILT-2.023: A Study of ALT-803, a Fusion Protein Activator of Natural Killer and T-Cells, in Combination With Pembrolizumab vs Pembrolizumab Alone as First-Line Treatment for Patients With Metastatic NSCLC.
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Research Joplin
mi
from
Joplin, MO
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of MTIG7192A in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwest Cancer Specialists-Vancouver
mi
from
Vancouver, WA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Lung Cancer Clinical Trial
A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Nassau
mi
from
Uniondale, NY
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Cleveland Clinic, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southdale Cancer Care, University of Minnesota Medical Center- Edina ( Site 0048)
mi
from
Edina, MN
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Status: Enrolling, Phase I, II
Updated: 12/31/1969
START Midwest
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology P A
mi
from
Dallas, TX
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Status: Enrolling, Phase III
Updated: 12/31/1969
Hca Midwest Division
mi
from
Kansas City, MO
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Oncology Associates, PC - HAL
mi
from
Sedona, AZ
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Specialists Panhandle
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Healthy Clinical Trial
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
Status: Enrolling, Phase
Updated: 12/31/1969
Sarkis Clinical Trials
mi
from
Ocala, FL
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
OK Clinical Research, LLC
mi
from
Edmond, OK
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Coastal Carolina Health Care, P.A.
mi
from
New Bern, NC
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Northwell Health
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Pasadena Center for Medical Research, Inc.
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Muncie, IN
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Expansion Study of RO7121661, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Rigshospitalet, Onkologisk Klinik
mi
from
København Ø,
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)
Status: Enrolling, Phase II
Updated: 12/31/1969
Kingston General Hospital
mi
from
Kingston,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Nassau
mi
from
Uniondale, NY
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Duarte, CA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Neoplasms Clinical Trial
Phase II Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Non-small Cell Lung Cancer NSCLC Clinical Trial
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fullerton, CA
Click here to add this to my saved trials
Non-small Cell Lung Cancer NSCLC Clinical Trial
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Metastatic Non-small Cell Lung Cancer (NSCLC) Clinical Trial
A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Salzburg,
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hinsdale, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials